141080 — LigaChem Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
KR₩4tn
Enterprise Value
KR₩3tn
Revenue
KR₩126bn

Annual balance sheet for LigaChem Biosciences, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	61,649	170,940	158,965	93,103	483,303
Net Total Accounts Receivable
Net Total Receivables	21,728	46,529	19,817	20,880	35,548
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	100,011	228,951	191,619	134,619	550,262
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,618	24,432	26,492	25,424	25,313
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	135,912	293,233	252,530	189,502	738,383
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14,009	17,018	28,603	37,072	117,183
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	23,786	34,459	32,932	41,281	122,385
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	112,126	258,775	219,599	148,221	615,998
Total Liabilities & Shareholders' Equity	135,912	293,233	252,530	189,502	738,383
Total Common Shares Outstanding
Total Preferred Shares Outstanding